(Q43796478)

26 November 2017

title

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease (English)

1 reference

26 November 2017

B V Khan

1

1 reference

26 November 2017

S Navalkar

2

1 reference

26 November 2017

Q A Khan

3

1 reference

26 November 2017

S T Rahman

4

1 reference

26 November 2017

S Parthasarathy

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

1662-1667

1 reference

Role of oxidized low density lipoprotein in atherogenesis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Reversing endothelial dysfunction with ACE inhibitors. A new trend

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Autoantibodies against oxidized LDL. A potential marker for atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Endothelium-Derived Relaxing Factors and Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Lucigenin chemiluminescence in the assessment of neutrophil superoxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Selective inhibition of cytosolic phospholipase A2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Vitamins C and E inhibit O2- production in the pig coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901615-1

7 January 2021

10.1016/S0735-1097(01)01615-1

Identifiers

DOI

1 reference

26 November 2017

1 reference